What is the market doing?
What the tape says about TSHA
Taysha Gene Therapies, Inc. is +87% over the past year while the S&P 500 is +20%: 67 points ahead of the market.
+87%
1-year return · S&P 500 +20%
- vs 200-day average
- +3.3%
vs 200-day average · close to trend
- RSI (14)
- 29
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 21%
Below its 52-week high
Details›
- Last close2026-09-08
- $5.48
- 1 monthS&P 500 −0.30%
- −14%
- 1 yearS&P 500 +20%
- +87%
- 5 yearsS&P 500 +85%
- −69%
- vs 50-day average$5.98
- −8.4%
- 52-week high
- $6.98
- 52-week low
- $2.83
- Annualised volatility
- 95%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$1.9M
| Year | Return |
|---|---|
| 2026 (year to date) | −0.36% |
| 2025 | +218% |
| 2024 | −2.3% |
| 2023 | −22% |
| 2022 | −81% |
| 2021 | −56% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 0 of 6 | −18% |
| Feb | 6 | 3 of 6 | +9.2% |
| Mar | 6 | 1 of 6 | −10% |
| Apr | 6 | 3 of 6 | +7.9% |
| May | 6 | 2 of 6 | +3.3% |
| Jun | 6 | 2 of 6 | −1.5% |
| Jul | 6 | 3 of 6 | −0.41% |
| Aug | 6 | 5 of 6 | +63% |
| Sep | 6 | 1 of 6 | −8.1% |
| Oct | 6 | 1 of 6 | −4.0% |
| Nov | 6 | 3 of 6 | +14% |
| Dec | 6 | 4 of 6 | −3.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.